Archive: 14/02/2019
Use of gastric acid suppressants may negatively impact survival outcomes in sarcoma patients treated with pazopanib
In patients with soft tissue sarcoma, the concomitant use of gastric acid suppressant (GAS) therapy and the anticancer therapeutic pazopanib (Votrient) was associated with significantly reduced progression-free survival and ...
Feb 14, 2019
Black-white cancer mortality gap nearly eliminated in some age groups
Although African Americans still bear a disproportionate share of the cancer burden, a new report finds the black-white gap has closed considerably over the past several decades. Cancer Statistics for African Americans and ...
Feb 14, 2019